Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease

COVID-19 is a disease caused by SARS-CoV-2, which has led to more than 4 million deaths worldwide. As a result, there is a worldwide effort to develop specific drugs for targeting COVID-19. Papain-like protease (PLpro) is an attractive drug target because it has multiple essential functions involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yunxia, Chen, Ke, Pan, Juanli, Lei, Yingshou, Zhang, Danting, Fang, Lipei, Tang, Jinle, Chen, Xin, Ma, Yanhong, Zheng, Yi, Zhang, Bao, Zhou, Yaoqi, Zhan, Jian, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342870/
https://www.ncbi.nlm.nih.gov/pubmed/34364941
http://dx.doi.org/10.1016/j.ijbiomac.2021.07.184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342870/
https://www.ncbi.nlm.nih.gov/pubmed/34364941
http://dx.doi.org/10.1016/j.ijbiomac.2021.07.184

Ejemplares similares